Literature DB >> 16939530

The combination of nuclear and mitochondrial mutations as a risk factor for idiosyncratic toxicity.

Daria LaRocca, David F Lehmann, Andras Perl, Takayuki Ozawa, Peter D Holohan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16939530      PMCID： PMC2000579          DOI： 10.1111/j.1365-2125.2006.02743.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  10 in total

1.  Combined glutathione-S-transferase M1 and T1 genetic polymorphism and tacrine hepatotoxicity.

Authors:  T Simon; L Becquemont; M Mary-Krause; I de Waziers; P Beaune; C Funck-Brentano; P Jaillon
Journal:  Clin Pharmacol Ther       Date:  2000-04       Impact factor: 6.875

Review 2.  Idiosyncratic drug reactions: the reactive metabolite syndromes.

Authors:  S R Knowles; J Uetrecht; N H Shear
Journal:  Lancet       Date:  2000-11-04       Impact factor: 79.321

Review 3.  New concepts in immunology relevant to idiosyncratic drug reactions: the "danger hypothesis" and innate immune system.

Authors:  J P Uetrecht
Journal:  Chem Res Toxicol       Date:  1999-05       Impact factor: 3.739

4.  Titrating the effects of mitochondrial complex I impairment in the cell physiology.

Authors:  A Barrientos; C T Moraes
Journal:  J Biol Chem       Date:  1999-06-04       Impact factor: 5.157

Review 5.  Advances in molecular toxicology-towards understanding idiosyncratic drug toxicity.

Authors:  B K Park; N R Kitteringham; H Powell; M Pirmohamed
Journal:  Toxicology       Date:  2000-11-16       Impact factor: 4.221

6.  Comparisons of oxidative metabolism and reductive capacity in sulfonamide-tolerant and -intolerant patients with human immunodeficiency virus.

Authors:  D F Lehmann; P D Holohan; D C Blair
Journal:  J Clin Pharmacol       Date:  1996-12       Impact factor: 3.126

Review 7.  The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance.

Authors:  J D Hayes; D J Pulford
Journal:  Crit Rev Biochem Mol Biol       Date:  1995       Impact factor: 8.250

8.  Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks.

Authors:  C L Chen; Q Liu; M V Relling
Journal:  Pharmacogenetics       Date:  1996-04

9.  A study to survey susceptible genetic factors responsible for troglitazone-associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus.

Authors:  Ichiro Watanabe; Aiko Tomita; Miho Shimizu; Mie Sugawara; Hiroaki Yasumo; Ryuta Koishi; Tohru Takahashi; Kaoru Miyoshi; Kouichi Nakamura; Takashi Izumi; Yasuyuki Matsushita; Hidehiko Furukawa; Hideyuki Haruyama; Teiichiro Koga
Journal:  Clin Pharmacol Ther       Date:  2003-05       Impact factor: 6.875

10.  Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signaling.

Authors:  K Banki; E Hutter; N J Gonchoroff; A Perl
Journal:  J Immunol       Date:  1999-02-01       Impact factor: 5.422
  10 in total
  4 in total

1.  Adverse drug reactions--no farewell to harms.

Authors:  Jeffrey K Aronson
Journal:  Br J Clin Pharmacol       Date:  2007-02       Impact factor: 4.335

2.  A case of melphalan sustained accumulation in an 80-year old patient.

Authors:  Pierre-Alain Jolivot; Vianney Poinsignon; Angelo Paci; Bertrand Guidet; Claire Pichereau; Christine Fernandez; Patrick Hindlet
Journal:  Int J Clin Pharm       Date:  2015-09-22

3.  Dapsone-associated methemoglobinemia in a patient with slow NAT2*5B haplotype and impaired cytochrome b5 reductase activity.

Authors:  Mahmoud Abouraya; James C Sacco; Kristie Hayes; Sajeve Thomas; Craig S Kitchens; Lauren A Trepanier
Journal:  J Clin Pharmacol       Date:  2012-02       Impact factor: 3.126

Review 4.  The plasma proteome, adductome and idiosyncratic toxicity in toxicoproteomics research.

Authors:  B Alex Merrick
Journal:  Brief Funct Genomic Proteomic       Date:  2008-02-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.